학술논문

Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers
Document Type
Article
Source
In: Oncologist. (Oncologist, July 2023, 28(7):618-623)
Subject
Language
English
ISSN
1549490X
10837159